Skip to main content

Table 1 Baseline demographic and disease features characteristics

From: Outcomes of hemi- versus whole liver transplantation in patients from mainland china with high model for end-stage liver disease scores: a matched analysis

Variables

MELD < 30

MELD ≥ 30

WG (n = 323)

HG (n = 323)

P

WG (n = 88)

HG (n = 35)

P

AgeDonor (years)

36.06 ± 11.95

36.3 ± 10.41

0.790

37.26 ± 15.75

37.66 ± 13.74

0.889

BMI Donor (kg/m2)

22.52 ± 2.24

22.78 ± 2.51

0.166

23.09 ± 2.33

22.73 ± 2.28

0.431

Age (years)

44.34 ± 10.15

43.76 ± 9.55

0.451

43.4 ± 10.88

44.55 ± 10.14

0.581

BMI (kg/m2)

22.41 ± 3.35

22.38 ± 3.1

0.923

22.76 ± 3.38

22.51 ± 2.79

0.677

Male (%)

265 (82%)

262 (81.1%)

0.761

30 (85.7%)

72 (81.8%)

0.604

CRE (μmoI/L)

72.54 ± 24.72

71.98 ± 24.33

0.774

140.78 ± 100.45

123.2 ± 100.83

0.384

ALB (g/L)

35.45 ± 6.61

35.04 ± 7.2

0.454

31.95 ± 4.77

32.32 ± 5.42

0.724

TB μmol/L

81.08 ± 125.71

73.22 ± 112.1

0.402

407.29 ± 219.85

406.91 ± 189.02

0.992

INR

1.35 ± 0.37

1.35 ± 0.37

0.960

3.11 ± 1.22

3.01 ± 1.1

0.646

PLT (109/L)

103.06 ± 82.96

96.59 ± 78.73

0.310

66.97 ± 44.95

67.05 ± 43.52

0.993

WBC (109/L)

5.65 ± 3.85

5.45 ± 3.41

0.486

9.3 ± 4.77

8.3 ± 4.95

0.309

HGB (g/L)

112.57 ± 27.68

112.12 ± 28.12

0.840

100.66 ± 24.02

98.77 ± 25.43

0.707

Tumor (%)

188 (58.2%)

185 (57.3%)

0.811

3 (8.6%)

8 (9.1%)

0.796

HBsAg positive (%)

231 (71.5%)

238 (73.7%)

0.537

27 (77.1%)

70 (79.5%)

0.768

Child–Pugh A (%)

68 (21.1%)

61 (18.9%)

0.491

0

0

NS

Child–Pugh B (%)

170 (52.6%)

168 (52%)

0.875

7 (20%)

10 (11.4%)

0.336

Child–Pugh C (%)

85 (26.3%)

94 (29.1%)

0.429

28 (80%)

78 (88.6%)

0.336

  1. BMI body mass index, CRE creatinine, ALB albumin, TB total bilirubin, INR International Normalized Ratio, MELD model end-stage liver disease, PLT platelet, WBC white blood cell, HGB hemoglobin, HBsAg hepatitis B surface antigen